The evidence
The Kanna Research Library.
Everything we say about kanna traces back to a source. This is that source list: every human study the kanna claims on this site rest on, summarized without spin, each with its PubMed ID and DOI so you can read the paper yourself. It is a small, young, mostly-Zembrin evidence base, and we say so plainly.
- 4
- core studies cited
- 3
- human trials
- ~74
- total participants (disclosed)
- 100%
- PMID-verified
Read this first: what the evidence is, and isn't
The human research on kanna is genuinely promising but genuinely small. It is a handful of short studies, most on one patented, standardized extract (Zembrin), several with industry involvement, and the largest enrolled 37 people. That is enough to describe a mechanism and a safety signal honestly. It is not enough to claim kanna treats any condition, and nobody here does. We cite these papers to stay grounded, not to oversell them.
The studies
In order of publication. Last reviewed 2026-07-01.
Harvey et al., 2011
Journal of EthnopharmacologyPharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids
Harvey AL, Young LC, Viljoen AM, Gericke NP (2011)
What it established: Identified kanna's dual mechanism, serotonin-reuptake inhibition (5-HT transporter) and PDE4 inhibition, in vitro.
Terburg et al., 2013
NeuropsychopharmacologyAcute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus
Terburg D, Syal S, Rosenberger LA, et al. (2013)
What it established: A single 25 mg dose of standardized extract reduced amygdala reactivity to fearful faces on fMRI (n=16).
Nell et al., 2013
Journal of Alternative and Complementary MedicineA randomized, double-blind, parallel-group, placebo-controlled trial of Extract Sceletium tortuosum (Zembrin) in healthy adults
Nell H, Siebert M, Chellan P, Gericke N (2013)
What it established: A 3-month placebo-controlled trial (n=37) found 8 mg and 25 mg/day were well-tolerated, with no significant changes in vitals or blood chemistry.
Chiu et al., 2014
Evidence-Based Complementary and Alternative MedicineProof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects
Chiu S, Gericke N, Farina-Woodbury M, et al. (2014)
What it established: A 3-week randomized study (n=21) reported improved cognitive set flexibility and executive function vs placebo.
Every claim traces to a source
If an article says kanna does something, it links the study behind it. No source, no claim.
We report the limits, not just the wins
Sample sizes, Zembrin-only scope, and industry involvement are stated, not buried.
Verified, never invented
Every PMID and DOI here was checked against PubMed. We would rather cite four real studies than forty fake ones.
Start with the science guides
This library summarizes published research for general education; it is not medical advice and study findings do not establish that kanna treats, cures, or prevents any condition. Kanna is a botanical supplement not evaluated by the FDA. Kanna raises serotonin, so do not combine it with SSRIs, SNRIs, MAOIs, or other serotonergic medications without medical advice, and avoid it in pregnancy.